期刊论文详细信息
BMC Pulmonary Medicine
Characteristics and prognostic implications of peripheral blood lymphocyte subsets in patients with anti-MDA5 antibody positive dermatomyositis-interstitial lung disease
Research
Ting Li1  Zhi-Ling Zhao1  Lin Feng1  Dong Wang1  Zhao-Hui Tong1  Xue-Lei Zang2  Lan Gao2  Xin-Ying Xue2  Ya-Wen Shen2  Fang-Ping Ren2  Qi Chen2  Wei-Chao Zhao3  Shan-Shan Yao4  Xin-Yu Bao5  Si-Wei Gu6 
[1] Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China;Beijing Shijitan Hospital, Capital Medical University, Beijing, China;PLA Strategic Support Force Medical Center, Beijing, China;University of Pittsburgh, Pittsburgh, USA;Weifang Medical College, Weifang, China;Xuanwu Hospital, Capital Medical University, Beijing, China;
关键词: Anti-melanoma differentiation-associated gene 5;    Dermatomyositis;    Interstitial lung disease;    Lymphocyte subsets;    Prognostic;   
DOI  :  10.1186/s12890-023-02706-y
 received in 2023-06-19, accepted in 2023-10-11,  发布年份 2023
来源: Springer
PDF
【 摘 要 】

ObjectivesTo examine the characteristics of blood lymphocyte subsets in dermatomyositis-interstitial lung disease (DM-ILD) inflicted patients with positive anti-melanoma differentiation-associated gene 5 (anti-MDA5), as well as its prognosis value in this set of patients.MethodsData were retrospectively collected from 253 DM-ILD patients from three hospitals in China between January 2016 to January 2021. Patients were grouped into anti-MDA5 antibody positive group (MDA5+ DM-ILD) and anti-MDA5 antibody negative group (MDA5− DM-ILD) based on myositis-specific autoantibody test results. Demographic characteristics, lymphocyte subsets patterns and other clinical features were compared between the two groups. The association of lymphocyte subsets with 180-day mortality was investigated using survival analysis in MDA5+ DM-ILD.ResultsOut of 253 eligible patients with DM-ILD, 59 patients were anti-MDA5+ and 194 were anti-MDA5−. Peripheral blood lymphocyte count, CD3+ count, percentage of CD3+, CD3+CD4+ count, and CD3+CD8+ count was lower in MDA5+ DM-ILD than in MDA5− DM-ILD− (all P < 0.001) as well as CD3−CD19+ count (P = 0.04). In MDA5+ DM-ILD, CD3+CD8+ count ≤ 49.22 cell/μL (HR = 3.81, 95%CI [1.20,12.14]) and CD3-CD19+ count ≤ 137.64 cell/μL (HR = 3.43, 95%CI [1.15,10.24]) were independent predictors of mortality. CD3+CD8+ count ≤ 31.38 cell/μL was associated with a higher mortality risk in all DM-ILD patients (HR = 8.6, 95%CI [2.12,31.44]) after adjusting for anti-MDA5 and other clinical characteristics.ConclusionSignificant lymphocytes decrease was observed in MDA5+ DM-ILD patients. CD3+CD8+ cell count was associated with worse prognosis in both MDA5+ DM-ILD and all DM-ILD patients.

【 授权许可】

CC BY   
© The Author(s) 2023

【 预 览 】
附件列表
Files Size Format View
RO202311103867073ZK.pdf 1386KB PDF download
40517_2023_273_Article_IEq4.gif 1KB Image download
12864_2017_3527_Article_IEq9.gif 1KB Image download
MediaObjects/12902_2023_1474_MOESM1_ESM.docx 28KB Other download
MediaObjects/12888_2023_5278_MOESM2_ESM.docx 20KB Other download
12951_2015_155_Article_IEq23.gif 1KB Image download
【 图 表 】

12951_2015_155_Article_IEq23.gif

12864_2017_3527_Article_IEq9.gif

40517_2023_273_Article_IEq4.gif

【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  • [11]
  • [12]
  • [13]
  • [14]
  • [15]
  • [16]
  • [17]
  • [18]
  • [19]
  • [20]
  • [21]
  • [22]
  • [23]
  • [24]
  • [25]
  • [26]
  • [27]
  • [28]
  • [29]
  • [30]
  • [31]
  • [32]
  • [33]
  • [34]
  • [35]
  • [36]
  • [37]
  文献评价指标  
  下载次数:38次 浏览次数:0次